Antinociception of spirocyclopiperazinium salt compound LXM-10-M targeting α7 nicotinic receptor and M4 muscarinic receptor and inhibiting CaMKIIα/CREB/CGRP signaling pathway in mice

详细信息    查看全文

• 作者：Dan Wan^a ; ¹ ; Ding Wang^a ; ¹ ; Qi Sun^b ; Yan Song^a ; YiMin Jiang^c ; RunTao Li^b ; Jia Ye^a ; ^{yejia@bjmu.edu.cn" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Methyllycaconitine (PubChem CID ; 494471) ; Tropicamide (PubChem CID ; 5593) ; Methoctramine (PubChem CID ; 107759) ; Aspirin (PubChem CID ; 2244) ; Morphine (PubChem CID ; 5288826) ; Formalin (PubChem CID ; 712) ; Acetic acid (PubChem CID ; 176)
• 刊名：European Journal of Pharmacology
• 出版年：2016
• 出版时间：5 January 2016
• 年：2016
• 卷：770
• 期：Complete
• 页码：92-98
• 全文大小：1920 K

文摘

The present study was designed to investigate the antinociception of spirocyclopiperazinium salt compound LXM-10-M (2,4-dimethyl-9-β-m-hydroxyphenylethyl-3-oxo-6, 9-diazaspiro [5.5] undecane chloride) in thermal and chemical pain models, and further to explore the molecular target and potential signal pathway. We assessed the antinociception of LXM-10-M in hot-plate test, formalin test and acetic acid writhing test in mice. The possible changes of calcium/calmodulin-dependent protein kinase IIα (CaMKIIα)/cAMP response element-binding protein (CREB)/calcitonin gene related peptide (CGRP) signaling pathway were detected by Western Blot in mice. Administration of LXM-10-M produced significant antinociception in hot-plate test, formalin test and acetic acid writhing test in mice, with no obvious toxicity. The antinociceptive effects were blocked by pretreatment with methyllycaconitine citrate (MLA, α7 nicotinic receptor antagonist) or tropicamide (TRO, M4 muscarinic receptor antagonist). Western blot analysis showed that the upregulations of p-CaMKIIα, p-CREB and CGRP in the spinal cord were reduced by LXM-10-M in chemical pain model in mice, and the effects were blocked by MLA or TRO pretreatment. This is the first paper to report that LXM-10-M exerted significant antinociception, which may be attributed to the activation of α7 nicotinic receptor and M4 muscarinic receptor and thereby triggering the inhibition of CaMKIIα/CREB/CGRP signaling pathway in mice.